FDA Inspection 1252414 — Shandong Guobang Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Guobang Pharmaceutical Co., Ltd. on Sep 27, 2024 in Weifang. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 27, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Weifang (China)